{"SPADE_UN_24466": {"Sequence Information": {"Peptide Name": "ACE2 (20-49)[6,21-R-ALA-7-oct; 13,28-ALA-4-pen]", "Sequence": "TIEEQXKTFLDKXNHEAEDLXYQSSLAXWN", "Sequence Length": 30, "Biological Activity": ["Antiviral", "Anticancer"], "Binding Target": "1. Virus entry", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q9BYF1", "uniprotUrl": "http://www.uniprot.org/uniprot/Q9BYF1", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro.", "Pubmed ID": "33310780", "Reference": "MBio. 2020;11:e02451-20", "Author": "Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33310780"}], "SPADE ID": "SPADE_UN_24466", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_24459", "Similarity": 1.0, "Sequence": "TIEEQAKTFLDKFNHEAEDLFYQSSLASWN"}, {"SPADE_ID": "SPADE_UN_13535", "Similarity": 1.0, "Sequence": "EDLFYQSSL"}, {"SPADE_ID": "SPADE_UN_24471", "Similarity": 0.8846153846153846, "Sequence": "TIEEQAKTLDKNHEAEDLYQSSLAWN"}], "Hemolytic Activity": "", "Target Organism": "SARS-CoV-2 PsV(IC50 I=2.9±0.27µM),SARS-CoV-2 PsV(IC50 I=2.68±0.14µM),Vesicular Stomatitis Virus (VSV) PsV(IC50 I=>26.8µM),Human lung carcinoma A549(50-60% Cytotoxicity=>26.8µM),Human fibrosarcoma HT1080(50-60% Cytotoxicity=>26.8µM),SARS-CoV-2(90-100% Inhibition=33.5µM)"}}}